Observational study on α-synucleinopathy
Official title: A Registered Observational Cohort Study on α-Synucleinopathy
Run by Fujian Medical University Union Hospital · NCT05527067 · Data updated 2026-11-12
This study is trying to learn more about diseases like Parkinson's and dementia by collecting information over time to help doctors understand how these conditions change and progress.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 30 Years to 80 Years |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Fujian Medical University Union Hospital Academic / other |
| Locations | 1 site (Fuzhou, Fujian) |
| Status | Recruiting |
| Started | September 1, 2021 |
| Main results expected | June 2030 |
| Study ends | June 2030 |
| Registry record updated | March 23, 2023 |
| Trial ID | NCT05527067 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals with a clinical diagnosis of primary α-synucleinopathy and unrelated healthy controls.
✕Probably not a fit
Patients with secondary α-synucleinopathy or other neurological disorders, as well as pregnant or lactating women, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on α-synucleinopathy, a group of neurodegenerative diseases that includes Parkinson's disease, multiple system atrophy, and dementia with Lewy bodies. It aims to collect data to enhance understanding of the natural history and progression of these conditions, utilizing multi-omics datasets. Data will be gathered both retrospectively at the time of research entry and prospectively during follow-up visits to aid healthcare providers in making informed medical decisions.
Why it matters
Potential benefit: If successful, this study could provide valuable insights that improve diagnosis and treatment strategies for patients with α-synucleinopathy.
How similar studies have gone: While this study is observational, similar studies have shown promise in understanding neurodegenerative diseases, suggesting potential for valuable findings.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants with a clinical diagnosis of primary α-synucleinopathy * Unrelated healthy controls Exclusion Criteria: * Patients with secondary α-synucleinopathy that cannot be excluded. * Patients with other neurological disorders. * Pregnant or lactating women.
Where it's running
-
Fujian Medical University Union Hospital
Fuzhou, Fujian, China Recruiting
Study contacts
- Study coordinator: Xiaodong Pan
- Email: pxd77316@163.com
- Phone: 0591-86218341
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Swedish BioFINDER Sleep program for early Parkinson's disease and REM sleep behavior disorder
This project will test whether sleep studies, brain and heart imaging, and fluid biomarkers can identify synuclein pathology and help predict progression in people with early Parkinson's disease or idiopathic REM sleep behavior disorder.
-
Treatment for constipation related to Parkinson's disease
This study is testing if a new medication called tenapanor can help people with Parkinson's disease who have constipation feel better by improving their bowel movements.
-
Characterization of the tumor microenvironment in locally advanced rectal cancer before and during neoadjuvant therapy
This observational study tests how the tumor and immune cells change in locally advanced rectal cancer from baseline to during neoadjuvant therapy using advanced genomic and immune profiling.
-
Intranasal insulin to reduce delirium after heart surgery with a heart-lung machine
This study tests whether giving intranasal insulin can reduce glycemic swings and delirium after elective heart surgery with cardiopulmonary bypass.
-
Aging Brain Health Initiative in Fujian
This observational study will follow about 3,000 older adults in Fujian to see how Alzheimer's-related changes develop and to test new digital tests, biomarkers, and imaging tools for early diagnosis.
-
Remote Ischemic Preconditioning at Different Times After Heart Valve Surgery
This study tests whether applying brief, controlled blood-flow restrictions to a limb at different times after heart valve surgery can help protect organs and reduce complications like kidney injury.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.